Is Littelfuse Inc (LFUS) a risky stock?
As of July 27, 2026, Clavix grades Littelfuse Inc (LFUS) C for risk, a composite score of 55 out of 100 on an A+ to F scale, which puts LFUS in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
The five risk dimensions behind LFUS's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how LFUS scores on each, as of July 27, 2026.
What's moving LFUS's risk right now
Company-specific signals Clavix flags behind LFUS's current grade, drawn from recent news and filings as of July 27, 2026.
A head-to-head with bigger peer Corning suggests Littelfuse is landing more Big Tech partnerships relative to its size, and management's long-term plan could help close part of the revenue gap.
A $16 million funding round for Prosper Medical was led by a venture capital firm called FUSE. FUSE has no connection to Littelfuse (LFUS), and the deal does not appear to affect the stock.
Recent LFUS news
The latest headlines Clavix ingested for Littelfuse Inc, newest first. These feed the news-sentiment dimension of LFUS's grade.
-
Article compares Littelfuse (LFUS) and Corning (GLW), noting Corning holds a 6x revenue advantage but Littelfuse is closing the gap with stronger recent momentum. Littelfuse outlined long-term strategic objectives at a May 2026 investor event and reported approximately 11% net income margin for Q1 2026 (quarter ended March 28, 2026); article body appears truncated with 'Continue reading'.
What a C grade means
On the Clavix A+ to F scale, LFUS's composite of 55 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell LFUS or any security. Grades are risk indicators, not predictions of return. Data may be delayed.